VERTEX PHARMACEUTICALS INC. NOTICE & PROXY

Company

VERTEX PHARMACEUTICALS INC / MA

Filed

April 3, 1997

Period of Report

May 8, 1997

Accession Number

0000950135-97-001628

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →